Reproductive and Family Health

Test Options

The following test options are currently available on our reproductive and family health websites. The links below will open in a new window.

Carrier screening
Highly accurate carrier screening that provides actionable information for your patients about the risks of passing on a genetic condition to their child.
Preimplantation genetic screening (PGS)
Advanced, next-generation sequencing, preimplantation genetic screening (PGS) that helps more patients find the path to pregnancy by optimizing IVF outcomes.
Preimplantation genetic diagnosis (PGD)
Highly specialized genetic testing designed for couples who have an increased risk of having a child with a specific genetic disorder or chromosomal abnormality based on their own genetic status. Can be used to detect most single-gene disorders and chromosomal translocations, while automatically screening for large numeric and structural chromosome abnormalities.
Prenatal diagnosis
High-sensitivity, whole genome chromosomal microarray analysis (CMA) evaluates for chromosomal abnormalities that can result in disorders of development and automatically evaluates for maternal cell contamination. Whole genome and targeted array options are available.
Miscarriage analysis
With greater detection rates than karyotyping, chromosomal microarray analysis (CMA) can determine if a pregnancy loss or stillbirth was due to a chromosomal abnormality. Testing can be performed on fresh tissue at the time of the loss as well as archived tissue in formalin-fixed, paraffin-embedded (FFPE) blocks.
Pediatric developmental disorders
High-sensitivity, whole genome chromosomal microarray analysis (CMA) evaluates for chromosomal copy number changes and other chromosomal abnormalities that can result in intellectual disabilities, developmental delays, multiple congenital anomalies, and autism spectrum disorders.